Recharge Your Mind™
Niraxx, a neurotech innovation company
Empowering individuals to take charge of their brain health for life.
As a mental health clinician, I have seen firsthand the inadequacy for current treatment options to serve every patient. While medications are the first-line treatment for depression, there is a huge unmet need to go beyond the one-size-fits-all approach. Since 2009, I have led multiple translational studies focused on treating patients with near-infrared light for mood and anxiety disorders. It’s tremendous that we can now make this effective, safe therapy available for anyone.
Brain health is a huge 21st century public health challenge and any effective, meaningful solution must start by making care accessible. We have successfully translated our wearable from device form factor to clothing form factor. That is only the beginning. We aim to build the world’s largest PBM digital platform where providers can meet and treat patients virtually.
CO-FOUNDER & CEO
With 20+ years of entrepreneurial experience, with a focus on light therapy, Joshua is the founder and chairman of two companies. In 2001, he founded his other company, Nature Bright Co., which makes and distributes light therapy products. Joshua has been nominated “Innovator of the Year” by the Orange County Business Journal for two consecutive years.
Paolo Cassano, MD, PhD
CO-FOUNDER & CHAIR OF SCIENTIFIC ADVISORY BOARD
Dr. Cassano is an Assistant Professor of Psychiatry at Harvard Medical School, and Director of Photobiomodulaiton at the Massachusetts General Hospital (MGH) Division of Neuropsychiatry and MGH Depression and Clinical Research Program. Dr. Cassano has over 10 years of experience in treatment of neuropsychiatric and mood and anxiety disorders with low level laser therapy and brain bioenergetics.
CHIEF COMMERCIAL OFFICER
Meg is a leader in the field of wearable technology for fitness and health. She was instrumental in commercializing the first wearable sensor garments while at Textronics, a startup later acquired by Adidas where she spent 10 years as Sr. Marketing Director, Commercial Development for digital products. Meg holds five patents in the area of connected wearable for sports and fitness.
Ronald Stoute, MSC, PHD
DIRECTOR OF PRODUCT ENGINEERING
Ronald is an expert on microsystem fabrication and mechanical engineering. He specializes in developing the next generation integrated circuit technology combining photonics with electronics. He is motivated to work on projects with an application in healthcare.
DIGITAL HEALTH ADVISOR
Beth is a serial entrepreneur, technology professional, and business strategist who has spent the last several years focused on digital medicine. She has 20+ years of technology executive experience, and is currently CEO of Signal 2 Health, a digital medicine product and strategy firm.
Dean STATHAKIS, PHD, JD
Dean has substantial experience in patent procurement, portfolio development, and life cycle management of intellectual property for clients in the biotechnology, pharmaceutical, life sciences, and high technology industries. His expertise include capital raising, new business/product launch and intellectual property licensing.
Michael DRUES, PhD
Michael is President of Vascular Sciences, an education, training, & consulting company offering a broad range of services to medical device, pharmaceutical & biotechnology companies ranging from startups to Fortune 100 companies.
Scientific Advisory Board
Alvaro Pascual-Leone, MD, PHD
Dr. Pascual-Leone is a Professor of Neurology at Harvard Medical School and Director of the Berenson-Allen Center at Beth Israel Deaconess Medical Center. His research aims at understanding the mechanisms that control brain plasticity across the life to prevent age-related cognitive decline, reduce the risk for dementia, and minimize the impact of neurodevelopmental disorders.
Maurizio Fava, MD
Dr. Fava founded and was Director of Massachusetts General Hospital’s (MGH) Depression Clinical and Research Program (DCRP), one of the most highly regarded depression programs in the U.S. He is a world leader in the field of depression and has authored and co-authored more than 800 original articles published in medical journals with international circulation.
Michael Hamblin, Phd
Dr. Hamblin is a Principal Investigator at MGH’s Wellman Center for Photomedicine, the world’s largest academic research facility dedicated to investigating the effects of light on human biology and to the development of photothearpy for multiple diseases. He is a world leader in the field of photomedicine.
Maria A. Franceschini, PHD
Dr. Franceschini is an Associate Professor in Radiology at Harvard Medical School. She is a pioneer in the field of near-infrared spectroscopy (NIRS), or the use of near-infrared light to quantify changes in hemoglobin concentration. Her research focuses on developing NIRS for brain health.
Jacek Dmochowski, PhD
Andre, R. Brunoni, Md, Phd
Dr. Brunoni is Director of two clinical and research centers at the University of Sao Paulo. His research focuses on the use of non-invasive brain stimulation techniques to treat multiple brain diseases.